A detailed history of En Rich Financial Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, En Rich Financial Partners LLC holds 56 shares of ABBV stock, worth $10,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56
Previous 56 -0.0%
Holding current value
$10,035
Previous $9.61 Million 15.14%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$159.82 - $182.1 $8,949 - $10,197
56 New
56 $10.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track En Rich Financial Partners LLC Portfolio

Follow En Rich Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of En Rich Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on En Rich Financial Partners LLC with notifications on news.